Literature DB >> 9285695

New deletion in low-grade oligodendroglioma at the glioblastoma suppressor locus on chromosome 10q25-26.

D Maier1, D Comparone, E Taylor, Z Zhang, O Gratzl, E G Van Meir, R J Scott, A Merlo.   

Abstract

Loss of heterozygosity on chromosome 10 is considered to be associated with the progression of glioblastomas. Two closely related regions have recently been proposed to contain the glioblastoma suppressor locus on chromosome 10q25-26; a 1 cM region between the polymorphic (CA)n-repeat markers D10S587 and D10S216, and an area of 5 cM between the markers D10S221 and D10S209. To confirm and further delineate this region, we analyzed 51 glioblastomas and 11 intermediate and low-grade gliomas for loss of heterozygosity on chromosome 10. 47/62 mostly malignant gliomas displayed complete loss of chromosome 10 and nine tumors were unaltered, whereas four glioblastomas and two low-grade oligodendrogliomas had partial loss on distal 10q. With these six tumors, we constructed a deletion map with increased marker density at 10q25-26 which shows two centromeric breakpoints at the markers D10S587 and D10S216, thus only confirming the distal, but not the proximal candidate glioblastoma suppressor locus. Two out of four low-grade oligodendrogliomas displayed partial deletions on 10q25-26. This suggests that deletion on chromosome 10 is not merely a late event in the progression of glioblastomas, but could play a role earlier in the development of gliomas.

Entities:  

Mesh:

Year:  1997        PMID: 9285695     DOI: 10.1038/sj.onc.1201209

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.

Authors:  H Sasaki; M C Zlatescu; R A Betensky; Y Ino; J G Cairncross; D N Louis
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.

Authors:  H Fujisawa; M Kurrer; R M Reis; Y Yonekawa; P Kleihues; H Ohgaki
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

3.  PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.

Authors:  C Dai; J C Celestino; Y Okada; D N Louis; G N Fuller; E C Holland
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

4.  Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas.

Authors:  Kinya Terada; Takashi Tamiya; Shigeru Daido; Hirokazu Kambara; Hiroaki Tanaka; Yasuhiro Ono; Kengo Matsumoto; Sachio Ito; Mamoru Ouchida; Takashi Ohmoto; Kenji Shimizu
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

Review 5.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

6.  FATS is a transcriptional target of p53 and associated with antitumor activity.

Authors:  Xifeng Zhang; Qian Zhang; Jun Zhang; Li Qiu; Shuang-Shuang Yan; Juling Feng; Yan Sun; Xingxu Huang; Karen H Lu; Zheng Li
Journal:  Mol Cancer       Date:  2010-09-16       Impact factor: 27.401

7.  soc-2 encodes a leucine-rich repeat protein implicated in fibroblast growth factor receptor signaling.

Authors:  L M Selfors; J L Schutzman; C Z Borland; M J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

8.  Rapid detection of allelic losses in brain tumours using microsatellite repeat markers and high-performance liquid chromatography.

Authors:  O B Chernova; G H Barnett; J K Cowell
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

Review 9.  Common fragile sites: genomic hotspots of DNA damage and carcinogenesis.

Authors:  Ke Ma; Li Qiu; Kristin Mrasek; Jun Zhang; Thomas Liehr; Luciana Gonçalves Quintana; Zheng Li
Journal:  Int J Mol Sci       Date:  2012-09-20       Impact factor: 6.208

10.  Loss of heterozygosity of TRIM3 in malignant gliomas.

Authors:  Jean-Louis Boulay; Urs Stiefel; Elisabeth Taylor; Béatrice Dolder; Adrian Merlo; Frank Hirth
Journal:  BMC Cancer       Date:  2009-02-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.